Safety-Focused Generative AI Agents for Healthcare Patient Communication

Hippocratic AI develops generative AI agents for healthcare organizations, targeting the administrative and patient-communication workload that surrounds clinical care rather than diagnosis or prescribing. Its customers are health systems, hospitals, payors and pharmaceutical companies. The company was founded by chief executive Munjal Shah, chief medical officer Meenesh Bhimani, chief product officer Vishal Parikh and chief science officer Subho Mukherjee, and frames its mission around a global shortage of roughly 15 million healthcare workers.

The platform rests on Polaris, described as a constellation architecture exceeding five trillion parameters: a 700-billion-parameter mixture-of-experts model at the center, ringed by supervisor models that each police one narrow concern. Separate specialists handle escalation protocols, medication recognition, drug-safety disambiguation, clinical deference, scheduling judgment, empathy and emotional safety, alongside audio-layer models for background speech, cough detection and voice quality. Outputs are graded by licensed clinicians against a harm scale rather than a single accuracy score.

Validation is the stated differentiator: the company reports a network of more than 7,500 US-licensed clinicians running over 725,000 test calls, and publishes per-supervisor benchmarks such as drug safety rising from 87.19 percent to 99.95 percent in version 5.0. More than a thousand pre-built agents span specialties from cardiology to oncology, trained on over 200 million patient interactions. The company states HIPAA compliance, HITRUST certification and SOC 2 attestation, and counts General Catalyst and a16z among its backers.